ArticleAntioxidants (Basel, Switzerland)2023

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.

Marie Angèle Cucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.